switching from semaglutide to retatrutide between weight-loss medications Retatrutide vs Semaglutide – Comparison

The SELECT trial proved a 20% MACE reduction

The trial participants also showed cardiovascular improvements after taking orforglipron, including lower systolic blood pressure, lower non-HDL cholesterol and lower triglycerides

This marks Pfizers second withdrawal of a danuglipron formulation, following the discontinuation of a twice-daily version in December 2023 due to tolerability issues

Microdosing GLP-1 oral liquid Microdosing GLP-1 has gained attention as an approach for people who want the metabolic benefits at lower side effect levels

Always consult a licensed healthcare provider before starting any new treatment

Who are these for